EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Lymphovenous Anastomosis for Treatment of Breast Lymphedema Following Delayed Autologous Reconstruction: A Case Report

Brianna M Peet iD, Benjamin D Wagner, Arianna Sidoti, Jonas A Nelson, Babak J Mehrara, Hidehiko Yoshimatsu

Microsurgery · 2026-07 · 46 (5)

DOI: 10.1002/micr.70267 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Microsurgery, online erschienen am 05.07.2026. Verfasst von Brianna M Peet und 5 weiteren Autor:innen. Beteiligte Einrichtung: Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Mammaplasty, Lymphedema, Breast Neoplasms, Postoperative Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast lymphedema (BLE) is an underrecognized sequela of breast cancer treatment that can lead to chronic swelling, pain, and recurrent infections. While lymphovenous anastomosis (LVA) is well established for the management of extremity lymphedema, its application to BLE has rarely been described. Here, we discuss a case of LVA for refractory BLE following delayed autologous reconstruction. A 49‐year‐old woman developed severe left‐sided BLE after deep inferior epigastric artery perforator flap reconstruction. The clinical course was complicated by nine episodes of cellulitis requiring hospital admission for intravenous treatment despite compliance with prophylactic antibiotics and compression therapy. The patient underwent indocyanine green (ICG)‐guided supermicrosurgical LVA within the reconstructed breast. Immediate postoperative decongestion was observed, and substantial reductions in breast pain and improvements in symmetry were reported 1 month postoperatively. At 10 months postoperatively, the patient maintained durable reductions in swelling and infection frequency. Our experience showed that LVA may be safely and effectively performed in the reconstructed breast and may represent a viable physiologic option for patients with refractory BLE unresponsive to conservative therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MammaplastyLymphedemaBreast NeoplasmsPostoperative ComplicationsLymphatic VesselsPerforator FlapHumansFemaleMiddle AgedAnastomosis, SurgicalMicrosurgeryVeinsMastectomy

Stichwörter der Autor:innen

autologous reconstructionbreast cancer‐related lymphedemabreast lymphedemacellulitislymphovenous anastomosis

Autor:innen und Institutionen

  • Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID-Profile: Brianna M Peet

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Peet, B. M., Wagner, B. D., Sidoti, A., Nelson, J. A., Mehrara, B. J., & Yoshimatsu, H. (2026). Lymphovenous Anastomosis for Treatment of Breast Lymphedema Following Delayed Autologous Reconstruction: A Case Report. Microsurgery, 46(5). https://doi.org/10.1002/micr.70267

Vancouver

Peet BM, Wagner BD, Sidoti A, Nelson JA, Mehrara BJ, Yoshimatsu H. Lymphovenous Anastomosis for Treatment of Breast Lymphedema Following Delayed Autologous Reconstruction: A Case Report. Microsurgery. 2026;46(5). doi:10.1002/micr.70267

BibTeX
@article{Peet2026,
  author = {Peet, Brianna M and Wagner, Benjamin D and Sidoti, Arianna and Nelson, Jonas A and Mehrara, Babak J and Yoshimatsu, Hidehiko},
  title = {Lymphovenous Anastomosis for Treatment of Breast Lymphedema Following Delayed Autologous Reconstruction: A Case Report},
  journal = {Microsurgery},
  year = {2026},
  volume = {46},
  number = {5},
  doi = {10.1002/micr.70267}
}
Kostenlos starten →